ADAMTS9 and breast cancer: Previous literature reported that LncRNA ADAMTS9-AS2 regulated chemoresistance in clear cell renal cell carcinoma [25], glioblastoma [26] and breast cancer [27], but no publications reported the involvement of LncRNA ADAMTS9-AS2 in the regulation of cisplatin resistance in GC cells.